These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21858228)

  • 1. Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor.
    Eriksson M; Andreasson K; Weidmann J; Lundberg K; Tegerstedt K; Dalianis T; Ramqvist T
    PLoS One; 2011; 6(8):e23828. PubMed ID: 21858228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor.
    Tegerstedt K; Franzén A; Ramqvist T; Dalianis T
    Cancer Immunol Immunother; 2007 Sep; 56(9):1335-44. PubMed ID: 17268793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8
    Pattinson DJ; Apte SH; Wibowo N; Rivera-Hernandez T; Groves PL; Middelberg APJ; Doolan DL
    Front Immunol; 2020; 11():564627. PubMed ID: 33133076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA-DR transgenic mouse model of prostate cancer.
    Riabov V; Tretyakova I; Alexander RB; Pushko P; Klyushnenkova EN
    Vaccine; 2015 Oct; 33(41):5386-5395. PubMed ID: 26319744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model.
    Simons BW; Cannella F; Rowley DT; Viscidi RP
    Cancer Immunol Immunother; 2020 Apr; 69(4):641-651. PubMed ID: 32016503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.
    Franzén AV; Tegerstedt K; Holländerova D; Forstová J; Ramqvist T; Dalianis T
    In Vivo; 2005; 19(2):323-6. PubMed ID: 15796193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors.
    Tegerstedt K; Lindencrona JA; Curcio C; Andreasson K; Tullus C; Forni G; Dalianis T; Kiessling R; Ramqvist T
    Cancer Res; 2005 Jul; 65(13):5953-7. PubMed ID: 15994974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice.
    Shu C; Sun P; Xie H; Huang W; Qi J; Ma Y
    Int J Nanomedicine; 2020; 15():1983-1996. PubMed ID: 32308382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunity induced by CpG ODN-adjuvanted virus-like particles containing Toxoplasma gondii proteins.
    Kang HJ; Chu KB; Kim MJ; Lee SH; Park H; Jin H; Moon EK; Quan FS
    Parasite Immunol; 2021 Jan; 43(1):e12799. PubMed ID: 33058167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer.
    Wang HL; Xu H; Lu WH; Zhu L; Yu YH; Hong FZ
    Arch Gynecol Obstet; 2014 Jan; 289(1):155-62. PubMed ID: 23912529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses.
    Maurer T; Pournaras C; Aguilar-Pimentel JA; Thalgott M; Horn T; Heck M; Heit A; Kuebler H; Gschwend JE; Nawroth R
    Urol Oncol; 2013 Oct; 31(7):1395-401. PubMed ID: 21982682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric Murine Polyomavirus Virus-Like Particles Induce
    Pattinson DJ; Apte SH; Wibowo N; Chuan YP; Rivera-Hernandez T; Groves PL; Lua LH; Middelberg APJ; Doolan DL
    Front Cell Infect Microbiol; 2019; 9():215. PubMed ID: 31275867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
    Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
    Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG.
    Song S; Wang Y; Zhang Y; Wang F; He Y; Ren D; Guo Y; Sun S
    Cancer Lett; 2007 Oct; 256(1):90-100. PubMed ID: 17656012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
    Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
    J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.
    Tegerstedt K; Franzén AV; Andreasson K; Joneberg J; Heidari S; Ramqvist T; Dalianis T
    Anticancer Res; 2005; 25(4):2601-8. PubMed ID: 16080500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour.
    Song S; Zhang K; You H; Wang J; Wang Z; Yan C; Liu F
    Clin Exp Immunol; 2010 Oct; 162(1):75-83. PubMed ID: 20735440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.